Reduced expression of actin‐binding proteins, h‐caldesmon and calponin h1, in the vascular smooth muscle inside melanoma lesions: an adverse prognostic factor for malignant melanoma

Summary Background 

[1]  J. Nakayama,et al.  Differential expression of smooth muscle alpha-like actin between benign and malignant human pigment tissues. , 1989, Cancer letters.

[2]  P. Carmeliet.  Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[3]  T. Kaku,et al.  Expression of α-Smooth Muscle Actin in Benign or Malignant Ovarian Tumors , 1993 .

[4]  R Folberg,et al.  Vasculogenic mimicry and tumor angiogenesis. , 2000, The American journal of pathology.

[5]  S. Taniguchi,et al.  The induction of smooth muscle alpha actin in a transformed rat cell line suppresses malignant properties in vitro and in vivo. , 1999, Cancer letters.

[6]  C Lenfant,et al.  NHLBI funding policies. Enhancing stability, predictability, and cost control. , 1994, Circulation.

[7]  E. Olson,et al.  Expression of the Smooth Muscle Cell Calponin Gene Marks the Early Cardiac and Smooth Muscle Cell Lineages during Mouse Embryogenesis (*) , 1996, The Journal of Biological Chemistry.

[8]  V. Koteliansky,et al.  Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. , 1992, Developmental biology.

[9]  H. Tsukamoto,et al.  Alpha-smooth muscle actin expression in tumor and stromal cells of benign and malignant human pigment cell tumors. , 1992, The Journal of investigative dermatology.

[10]  E. Abel.  Clinical applications of research on angiogenesis , 1996 .

[11]  J. Nakayama,et al.  Human malignant melanoma cells release a factor that inhibits the expression of smooth muscle alpha-actin. , 2000, Journal of dermatological science.

[12]  T. Ohhashi,et al.  B16-BL6 melanoma cells release inhibitory factor(s) of active pump activity in isolated lymph vessels. , 2001, American journal of physiology. Cell physiology.

[13]  C. Otey,et al.  Role of Adhesion Molecule Cytoplasmic Domains in Mediating Interactions with the Cytoskeleton , 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[14]  R. Green,et al.  Cloning and expression of a novel acidic calponin isoform from rat aortic vascular smooth muscle. , 1994, The Journal of biological chemistry.

[15]  J. Small,et al.  Smooth muscle specific expression of calponin , 1990, FEBS letters.

[16]  M. Katsuki,et al.  Structural fragility of blood vessels and peritoneum in calponin h1-deficient mice, resulting in an increase in hematogenous metastasis and peritoneal dissemination of malignant tumor cells. , 2001, Cancer research.

[17]  T. Nikaido,et al.  Possible role of calponin h1 as a tumor suppressor in human uterine leiomyosarcoma. , 1999, Journal of the National Cancer Institute.

[18]  J. Sagara,et al.  Calponin h1 induced a flattened morphology and suppressed the growth of human fibrosarcoma HT1080 cells. , 2002, European journal of cancer.

[19]  J. Nakayama,et al.  Malignant schwannoma in a case of type 1 neurofibromatosis with decreased immunoreactivity of smooth muscle alpha-actin in tumor vessels. , 1994, Journal of dermatological science.

[20]  R. Dobson,et al.  British Association of Dermatologists , 2014 .

[21]  E. Morrisey,et al.  Developmental Pattern of Expression and Genomic Organization of the Calponin-h1 Gene , 1996, The Journal of Biological Chemistry.

[22]  K. Tanaka,et al.  Molecular cloning and characterization of human non-smooth muscle calponin. , 1996, Journal of biochemistry.

[23]  B. Nadal-Ginard,et al.  Molecular cloning and sequence analysis of smooth muscle calponin. , 1991, The Journal of biological chemistry.

[24]  A. Ackerman,et al.  Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas. , 1985, Human pathology.

[25]  N. Glazer,et al.  Angiopoietin-1 protects the adult vasculature against plasma leakage , 2000, Nature Medicine.

[26]  A. Gown,et al.  Immunolocalization of three novel smooth muscle-specific proteins in salivary gland pleomorphic adenoma: assessment of the morphogenetic role of myoepithelium. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[27]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[28]  A. Bretscher.  Caldesmon: Thin filament regulatory proteins of smooth- and non-muscle cells , 1986, Nature.

[29]  塚本 秀和.  α-smooth muscle actin expression in tumor and stromal cells of benign and malignant human pigment cell tumors , 1993 .

[30]  J. Small,et al.  Calponin and SM 22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. , 1993, Differentiation; research in biological diversity.

[31]  S. Winder,et al.  Regulation of smooth muscle actin-myosin interaction and force by calponin. , 1998, Acta physiologica Scandinavica.

[32]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.

[33]  A Kusumi,et al.  Mobility and cytoskeletal interactions of cell adhesion receptors. , 1999, Current opinion in cell biology.